Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Nilsson

Showing results (101-110 of 343) with videos related to

Pageof 35
Sort By:
Plos One|March 14, 2015
Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old womenBjörn Fagerberg, Ulrica Prahl Gullberg, Ragnar Alm, et al.
Atherosclerosis|February 15, 2011
Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS)Gerd Ostling, Isabel Gonçalves, John Wikstrand, et al.
Cardiovascular Diabetology|May 12, 2019
Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammationMichaela Kozakova, Carmela Morizzo, Isabel Goncalves, et al.
Clinical Medicine Insights. Cardiology|September 14, 2020
Carotid Plaque Morphology is Similar in Patients with Reduced and Normal Renal FunctionCaroline Heijl, Fredrik Kahn, Andreas Edsfeldt, et al.
Cardiovascular Research|May 29, 2014
Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- miceDaniel Engelbertsen, Sara Rattik, Anki Knutsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 27, 2016
Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary EventsHarry Björkbacka, Ragnar Alm, Margaretha Persson, et al.
Journal of the American Heart Association|September 15, 2016
Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control StudyAlexandru Schiopu, Eva Bengtsson, Isabel Gonçalves, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca<sup>2+</sup> /K<sup>+</sup> channel flowJinyu Su, Hui Zhou, Xianyan Liu, et al.
Immunologic Research|January 25, 2013
Immune responses elicited by apoB-100-derived peptides in miceChrysoulla Pierides, Alexandra Bermudez-Fajardo, Gunilla Nordin Fredrikson, et al.
Clinical Proteomics|March 30, 2021
The associations between red cell distribution width and plasma proteins in a general populationJingxue Pan, Yan Borné, Marju Orho-Melander, et al.
Pageof 35

Showing results (101-110 of 343) with videos related to

Sort By:
Pageof 35
Plos One|March 14, 2015
Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old womenBjörn Fagerberg, Ulrica Prahl Gullberg, Ragnar Alm, et al.
Atherosclerosis|February 15, 2011
Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS)Gerd Ostling, Isabel Gonçalves, John Wikstrand, et al.
Cardiovascular Diabetology|May 12, 2019
Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammationMichaela Kozakova, Carmela Morizzo, Isabel Goncalves, et al.
Clinical Medicine Insights. Cardiology|September 14, 2020
Carotid Plaque Morphology is Similar in Patients with Reduced and Normal Renal FunctionCaroline Heijl, Fredrik Kahn, Andreas Edsfeldt, et al.
Cardiovascular Research|May 29, 2014
Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- miceDaniel Engelbertsen, Sara Rattik, Anki Knutsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 27, 2016
Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary EventsHarry Björkbacka, Ragnar Alm, Margaretha Persson, et al.
Journal of the American Heart Association|September 15, 2016
Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control StudyAlexandru Schiopu, Eva Bengtsson, Isabel Gonçalves, et al.
Journal of Cellular and Molecular Medicine|December 21, 2016
oxLDL antibody inhibits MCP-1 release in monocytes/macrophages by regulating Ca<sup>2+</sup> /K<sup>+</sup> channel flowJinyu Su, Hui Zhou, Xianyan Liu, et al.
Immunologic Research|January 25, 2013
Immune responses elicited by apoB-100-derived peptides in miceChrysoulla Pierides, Alexandra Bermudez-Fajardo, Gunilla Nordin Fredrikson, et al.
Clinical Proteomics|March 30, 2021
The associations between red cell distribution width and plasma proteins in a general populationJingxue Pan, Yan Borné, Marju Orho-Melander, et al.
Pageof 35